HERUDKOVÁ, Zdeňka, Martin ČULEN, Adam FOLTA, Ivana JEŽÍŠKOVÁ, Jana CERNA, Tomáš LOJA, Nikola TOM, Jiri SMEJKAL, Lukáš SEMERÁD, Dana DVOŘÁKOVÁ, Jiří MAYER and Zdeněk RÁČIL. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia. British journal of haematology. Hoboken: Wiley-Blackwell, vol. 190, No 4, p. 562-572. ISSN 0007-1048. doi:10.1111/bjh.16341. 2020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Clonal hierarchy of main molecular lesions in acute myeloid leukaemia
Authors HERUDKOVÁ, Zdeňka (203 Czech Republic, belonging to the institution), Martin ČULEN (703 Slovakia, belonging to the institution), Adam FOLTA (203 Czech Republic), Ivana JEŽÍŠKOVÁ (203 Czech Republic), Jana CERNA (203 Czech Republic), Tomáš LOJA (703 Slovakia, belonging to the institution), Nikola TOM (203 Czech Republic, belonging to the institution), Jiri SMEJKAL (203 Czech Republic), Lukáš SEMERÁD (203 Czech Republic), Dana DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, guarantor, belonging to the institution).
Edition British journal of haematology, Hoboken, Wiley-Blackwell, 2020, 0007-1048.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.998
RIV identification code RIV/00216224:14110/20:00115741
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/bjh.16341
UT WoS 000501700400001
Keywords in English acute myeloid leukaemia; mutations; relapse; patient-derived xenograft; clonality
Tags 14110212, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 22/9/2020 07:32.
Abstract
Genetic mutations in acute myeloid leukaemia (AML) are assumed to occur in a sequential order; however, the predominant hierarchical roles of specific mutated genes have not been fully described. In this study, we aimed to determine the clonal involvement of the most frequent AML-associated mutations. Using a targeted sequencing panel for 18 genes, we traced changes and relative clonal contribution of mutations in 52 patients. We analysed 35 pairs of diagnosis and relapse samples, 27 pairs of primary samples and corresponding patient-derived xenografts, and 34 pairs of total leukocytes and corresponding isolated primitive cells or blast populations. In both relapse and xenografts, we observed conservation of main leukaemic clones and variability was limited to subclones with late-acquired mutations. AML evolution thus mainly involved modification of subclones while the clonal background remained unchanged. NPM1 mutations were identified as the most probable leukaemia-transformation lesion, remaining conserved in contrast to high variation of accompanying subclonal FLT3 and NRAS mutations. DNMT3A mutations represented the most stable mutations forming a preleukaemic background in most samples. Mutations in genes IDH1/2, TET2, RUNX1, ASXL1 and U2AF1 were detected both as preleukaemic and as subclonal lesions, suggesting a non-specific order of acquisition.
Links
MUNI/A/1105/2018, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VI (Acronym: VýDiTeHeMA VI)
Investor: Masaryk University, Category A
NV15-25809A, research and development projectName: Národní program studia mutací a klonality leukemických buněk u pacientů s akutní myeloidní leukémií
PrintDisplayed: 16/4/2024 23:27